What is the New Name for Monkey Pox?
The World Health Organization (WHO) recently announced a new name for monkeypox, a disease that has been causing concern worldwide. The new name, “mpox,” aims to reduce stigma and confusion associated with the previous name. This article will explore the reasons behind the change and the implications it may have on public health efforts.
Monkeypox is a viral disease that was first identified in monkeys in 1958. However, it is now known to affect humans as well. The disease is caused by the monkeypox virus, which is closely related to the variola virus that causes smallpox. Although smallpox has been eradicated, monkeypox remains a threat to public health.
The decision to change the name from “monkeypox” to “mpox” was made in response to concerns that the original name could perpetuate stigma and discrimination against people affected by the disease. The WHO has been working on this issue for several years, and in May 2022, they officially announced the new name.
The new name, “mpox,” is derived from the prefix “mpo,” which is a common abbreviation for “monkeypox.” The “x” at the end is a common practice in naming viruses, such as HIV (Human Immunodeficiency Virus) and HPV (Human Papillomavirus). The WHO hopes that the new name will be easier for people to pronounce and understand, while also reducing the stigma associated with the disease.
The change in name is part of a broader effort by the WHO to address the stigma and discrimination faced by people affected by infectious diseases. Stigma can lead to social isolation, discrimination, and barriers to accessing healthcare, which can worsen the public health impact of these diseases.
In addition to changing the name, the WHO has also been working on improving the global response to mpox. This includes enhancing surveillance, improving diagnostic tools, and developing vaccines and treatments. The organization has also been advocating for increased funding and resources to combat the disease.
The new name for mpox is expected to have several implications for public health efforts. First, it may help to reduce stigma and discrimination, making it easier for people to seek medical care and support. Second, it may improve communication and collaboration among healthcare providers, researchers, and policymakers. Finally, it may help to increase public awareness and understanding of the disease, leading to better prevention and control measures.
In conclusion, the new name for monkeypox, “mpox,” is a significant step towards reducing stigma and improving the global response to this disease. As the world continues to grapple with infectious diseases, it is crucial to address the social and cultural factors that contribute to their spread and impact. The WHO’s efforts to rename mpox and improve the global response to the disease are an important part of this broader effort.
